These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22699537)

  • 21. Resting-state fMRI reveals potential neural correlates of impaired cognition in Huntington's disease.
    Liu W; Yang J; Chen K; Luo C; Burgunder J; Gong Q; Shang H
    Parkinsonism Relat Disord; 2016 Jun; 27():41-6. PubMed ID: 27117563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-literal language deficits in mild cognitive impairment.
    Cardoso S; Silva D; Maroco J; de Mendonça A; Guerreiro M
    Psychogeriatrics; 2014 Dec; 14(4):222-8. PubMed ID: 25495083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load.
    Wolf RC; Sambataro F; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer B
    Eur J Neurol; 2008 Nov; 15(11):1180-90. PubMed ID: 18754766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease.
    Hart EP; Marinus J; Burgunder JM; Bentivoglio AR; Craufurd D; Reilmann R; Saft C; Roos RA;
    Mov Disord; 2013 Jul; 28(8):1142-5. PubMed ID: 23495076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Beglinger LJ; Duff K; Allison J; Theriault D; O'Rourke JJ; Leserman A; Paulsen JS
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):573-8. PubMed ID: 19882420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validity of the Montreal Cognitive Assessment in the detection of cognitive dysfunction in Huntington's disease.
    Bezdicek O; Majerova V; Novak M; Nikolai T; Ruzicka E; Roth J
    Appl Neuropsychol Adult; 2013; 20(1):33-40. PubMed ID: 23373682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Huntington Study Group Reach2HD Investigators
    Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.
    Aziz NA; Anguelova GV; Marinus J; Lammers GJ; Roos RA
    Parkinsonism Relat Disord; 2010 Jun; 16(5):345-50. PubMed ID: 20236854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution to the evaluation of language disturbances in subcortical lesions: a pilot study.
    Radanovic M; Mansur LL; Azambuja MJ; Porto CS; Scaff M
    Arq Neuropsiquiatr; 2004 Mar; 62(1):51-7. PubMed ID: 15122433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian.
    Nemeth D; Dye CD; Sefcsik T; Janacsek K; Turi Z; Londe Z; Klivenyi P; Kincses ZT; Szabó N; Vecsei L; Ullman MT
    Brain Lang; 2012 Jun; 121(3):248-53. PubMed ID: 22538085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for specific cognitive deficits in preclinical Huntington's disease.
    Lawrence AD; Hodges JR; Rosser AE; Kershaw A; ffrench-Constant C; Rubinsztein DC; Robbins TW; Sahakian BJ
    Brain; 1998 Jul; 121 ( Pt 7)():1329-41. PubMed ID: 9679784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive and Motor Norms for Huntington's Disease.
    Mills JA; Long JD; Mohan A; Ware JJ; Sampaio C
    Arch Clin Neuropsychol; 2020 Aug; 35(6):671-682. PubMed ID: 32407458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease.
    Rodrigues GR; Souza CP; Cetlin RS; de Oliveira DS; Pena-Pereira M; Ujikawa LT; Marques W; Tumas V
    J Neurol; 2009 Nov; 256(11):1809-15. PubMed ID: 19536583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
    Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
    Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year.
    Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
    Acta Neurol Scand; 2002 Sep; 106(3):131-41. PubMed ID: 12174172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between motor and cognitive disorders in Huntington's disease.
    Girotti F; Marano R; Soliveri P; Geminiani G; Scigliano G
    J Neurol; 1988 Nov; 235(8):454-7. PubMed ID: 2974882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Productive syntax abilities in Huntington's and Parkinson's diseases.
    Murray LL; Lenz LP
    Brain Cogn; 2001; 46(1-2):213-9. PubMed ID: 11527333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dementia and cognitive changes in Huntington's disease.
    Morris M
    Adv Neurol; 1995; 65():187-200. PubMed ID: 7872140
    [No Abstract]   [Full Text] [Related]  

  • 39. Language impairment in sporadic and familial (type 8) amyotrophic lateral sclerosis: A comparative study.
    de Araújo CM; de Alcântara C; Alencar MA; da Gama NAS; Cruzeiro MM; França MC; Jaeger A; Camargos ST; Machado TH; de Souza LC
    Muscle Nerve; 2024 Jul; 70(1):130-139. PubMed ID: 38738747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Language Disorders in Huntington Disease: A Systematic Literature Review.
    Gagnon M; Barrette J; Macoir J
    Cogn Behav Neurol; 2018 Dec; 31(4):179-192. PubMed ID: 30562227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.